Bernard F. Cole

17.2k total citations · 1 hit paper
179 papers, 9.3k citations indexed

About

Bernard F. Cole is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Bernard F. Cole has authored 179 papers receiving a total of 9.3k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Oncology, 42 papers in Pulmonary and Respiratory Medicine and 34 papers in Cancer Research. Recurrent topics in Bernard F. Cole's work include Breast Cancer Treatment Studies (25 papers), Statistical Methods in Clinical Trials (18 papers) and Health Systems, Economic Evaluations, Quality of Life (15 papers). Bernard F. Cole is often cited by papers focused on Breast Cancer Treatment Studies (25 papers), Statistical Methods in Clinical Trials (18 papers) and Health Systems, Economic Evaluations, Quality of Life (15 papers). Bernard F. Cole collaborates with scholars based in United States, Italy and Switzerland. Bernard F. Cole's co-authors include Richard D. Gelber, Michael Glantz, Aron Goldhirsch, Lawrence D. Recht, Leila A. Mott, Andrew J. Saykin, Charlotte T. Furstenberg, Tim A. Ahles, John A. Baron and Robert S. Sandler and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Bernard F. Cole

176 papers receiving 8.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Practice parameter: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors [RETIRED]

2000 537 citations Michael Glantz, Bernard F. Cole et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bernard F. Cole United States	54	3.6k	3.6k	2.1k	1.4k	1.3k	179	9.3k
Renato Lenzi United States	45	4.8k 1.3×	2.3k 0.6×	657 0.3×	1.8k 1.3×	1.0k 0.8×	99	9.8k
Xuemei Wang United States	54	2.8k 0.8×	3.1k 0.9×	1.8k 0.9×	1.8k 1.3×	1.0k 0.8×	252	10.4k
Stuart A. Grossman United States	63	4.5k 1.2×	3.6k 1.0×	6.3k 3.1×	1.3k 0.9×	1.7k 1.3×	346	14.4k
Lene Mellemkjær Denmark	55	2.6k 0.7×	1.5k 0.4×	956 0.5×	1.9k 1.4×	1.4k 1.1×	209	11.4k
Faith G. Davis United States	47	2.5k 0.7×	2.9k 0.8×	3.0k 1.4×	705 0.5×	1.4k 1.1×	147	10.4k
Paul A. Decker United States	54	1.4k 0.4×	4.2k 1.2×	1.5k 0.7×	1.2k 0.9×	562 0.4×	255	9.7k
Florence Joly France	50	2.8k 0.8×	3.3k 0.9×	902 0.4×	1.0k 0.7×	746 0.6×	330	7.9k
Judith R. OʼFallon United States	58	2.2k 0.6×	3.3k 0.9×	5.6k 2.7×	950 0.7×	1.5k 1.1×	125	11.2k
Sijin Wen United States	52	3.0k 0.8×	2.8k 0.8×	2.2k 1.1×	1.4k 1.0×	1.5k 1.1×	302	10.4k
Vittorina Zagonel Italy	52	5.3k 1.5×	2.4k 0.7×	2.3k 1.1×	1.4k 1.0×	1.4k 1.1×	467	11.4k

Countries citing papers authored by Bernard F. Cole

Since Specialization

Citations

This map shows the geographic impact of Bernard F. Cole's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernard F. Cole with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernard F. Cole more than expected).

Fields of papers citing papers by Bernard F. Cole

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernard F. Cole. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernard F. Cole. The network helps show where Bernard F. Cole may publish in the future.

Co-authorship network of co-authors of Bernard F. Cole

This figure shows the co-authorship network connecting the top 25 collaborators of Bernard F. Cole. A scholar is included among the top collaborators of Bernard F. Cole based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernard F. Cole. Bernard F. Cole is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gibson, Pamela Church, et al.. (2024). Initial Safety and Feasibility Results From a Phase 1, Diagnose-and-Treat Trial of Neoadjuvant Intratumoral Cisplatin for Stage IV NSCLC. JTO Clinical and Research Reports. 5(3). 100634–100634. 1 indexed citations

Cole, Bernard F., et al.. (2022). Weekly vs Every-3-Week Carboplatin with Weekly Paclitaxel in Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer: A Retrospective Analysis. Breast Cancer Targets and Therapy. Volume 14. 63–70. 2 indexed citations

Leone, José Pablo, Bernard F. Cole, Meredith M. Regan, et al.. (2020). Clinical behavior of recurrent hormone receptor–positive breast cancer by adjuvant endocrine therapy within the Breast International Group 1‐98 clinical trial. Cancer. 127(5). 700–708. 5 indexed citations

Li, Zhigang, H. Robert Frost, Tor D. Tosteson, et al.. (2017). A semiparametric joint model for terminal trend of quality of life and survival in palliative care research. Statistics in Medicine. 36(29). 4692–4704. 10 indexed citations

Kinsey, C. Matthew, Raúl San Jośe Estépar, Jos van der Velden, et al.. (2016). Lower Pectoralis Muscle Area Is Associated with a Worse Overall Survival in Non–Small Cell Lung Cancer. Cancer Epidemiology Biomarkers & Prevention. 26(1). 38–43. 58 indexed citations

Karlsson, Per, Bernard F. Cole, Karen N. Price, et al.. (2016). Timing of Radiation Therapy and Chemotherapy After Breast-Conserving Surgery for Node-Positive Breast Cancer: Long-Term Results From International Breast Cancer Study Group Trials VI and VII. International Journal of Radiation Oncology*Biology*Physics. 96(2). 273–279. 19 indexed citations

North, William G., et al.. (2014). Growth Impairment of Small-Cell Cancer by Targeting Pro-Vasopressin with MAG-1 Antibody. Frontiers in Oncology. 4. 16–16. 5 indexed citations

Colleoni, Marco, Bernard F. Cole, Giuseppe Viale, et al.. (2010). Classical Cyclophosphamide, Methotrexate, and Fluorouracil Chemotherapy Is More Effective in Triple-Negative, Node-Negative Breast Cancer: Results From Two Randomized Trials of Adjuvant Chemoendocrine Therapy for Node-Negative Breast Cancer. Journal of Clinical Oncology. 28(18). 2966–2973. 109 indexed citations

Gruber, Guenther, Bernard F. Cole, Monica Castiglione‐Gertsch, et al.. (2008). Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancer. Annals of Oncology. 19(8). 1393–1401. 26 indexed citations

10.

Olson, Ardis L., et al.. (2006). SunSafe in the middle school years: A community-wide intervention to change early adolescent sun protection.. Cancer Epidemiology and Prevention Biomarkers. 15. 2 indexed citations

11.

Cole, Bernard F., John A. Baron, Robert S. Sandler, et al.. (2005). Decreases in gamma-tocopherol, but not alpha-tocopherol, with a low-fat diet. Cancer Research. 65. 1041–1041. 9 indexed citations

12.

Robertson, Douglas J., E. Robert Greenberg, Michael L. Beach, et al.. (2005). Colorectal Cancer in Patients Under Close Colonoscopic Surveillance. Gastroenterology. 129(1). 34–41. 340 indexed citations

13.

Mesbah, Mounir, et al.. (2002). Statistical methods for quality of life studies : design, measurements and analysis. Data Archiving and Networked Services (DANS). 29 indexed citations

14.

Lewis, Lionel D., Bernard F. Cole, Paul K. Wallace, et al.. (2001). Pharmacokinetic–pharmacodynamic relationships of the bispecific antibody MDX-H210 when administered in combination with interferon gamma: a multiple-dose phase-I study in patients with advanced cancer which overexpresses HER-2/neu. Journal of Immunological Methods. 248(1-2). 149–165. 21 indexed citations

15.

Bonetti, Marco, Bernard F. Cole, & Richard D. Gelber. (1999). A Method-of-Moments Estimation Procedure for Categorical Quality-of-Life Data with Nonignorable Missingness. Journal of the American Statistical Association. 94(448). 1025–1034. 7 indexed citations

16.

Choy, H., Wallace Akerley, Howard Safran, et al.. (1998). Multiinstitutional phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer.. Journal of Clinical Oncology. 16(10). 3316–3322. 190 indexed citations

17.

Friedberg, Marc H., Michael Glantz, Mark S. Klempner, Bernard F. Cole, & George Perides. (1998). Specific matrix metalloproteinase profiles in the cerebrospinal fluid correlated with the presence of malignant astrocytomas, brain metastases, and carcinomatous meningitis. Cancer. 82(5). 923–930. 79 indexed citations

18.

Chung, Maureen A., Bernard F. Cole, Harold J. Wanebo, Kirby I. Bland, & Helena R. Chang. (1997). Optimal surgical treatment of invasive lobular carcinoma of the breast. Annals of Surgical Oncology. 4(7). 545–550. 46 indexed citations

19.

Glantz, Michael, H. Choy, Wallace Akerley, et al.. (1997). Weekly paclitaxel with and without concurrent radiation therapy: Toxicity, pharmacokinetics, and response. Seminars in Radiation Oncology. 7. 7 indexed citations

20.

Gelber, Richard D., Bernard F. Cole, Aron Goldhirsch, et al.. (1995). Adjuvant chemotherapy for premenopausal breast cancer: a meta-analysis using quality-adjusted survival. Cancer Discovery. 1(2). 114–121. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact